Better Therapeutics Inc. (BTTX)
0.00
-0.00 (-100.00%)
At close: Feb 28, 2025, 2:38 PM
Company Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States.
Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes.
The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels.
Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
Better Therapeutics Inc.
| Country | United States |
| IPO Date | Mar 17, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 54 |
| CEO | David P. Perry M.B.A. |
Contact Details
Address: 548 Market Street San Francisco, California United States | |
| Website | https://www.bettertx.com |
Stock Details
| Ticker Symbol | BTTX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001832415 |
| CUSIP Number | 08773T104 |
| ISIN Number | US08773T1043 |
| Employer ID | 00-0000000 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Frank L. Karbe M.B.A. | Interim Chief Financial Officer & Director |
| Andres Camacho | Senior Vice President of Technology & Head of Engineering |
| Angela Willis | Senior Vice President of Market Access |
| David P. Perry M.B.A. | Co-Founder & Executive Chairman |
| Dr. Mark A. Berman M.D. | Chief Medical Officer |
| Jessica Meng | Chief Commercial Officer |
| Kristin Wynholds | Chief Product Officer |
| Leslie Miller | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 30, 2024 | 15-12G | Filing |
| May 23, 2024 | POS AM | Filing |
| May 23, 2024 | POS AM | Filing |
| May 23, 2024 | POS AM | Filing |
| May 23, 2024 | POS AM | Filing |
| May 23, 2024 | POS AM | Filing |
| May 23, 2024 | S-8 POS | Filing |
| May 23, 2024 | S-8 POS | Filing |
| May 16, 2024 | 25-NSE | Filing |
| Mar 21, 2024 | 424B3 | Filing |